Investigational PDE-5 inhibitor comparable to sildenafil, study shows

A phase II study comparing the onset of action of two oral phosphodiesterase-type 5 inhibitors?TA-1790, an investigational agent and sildenafil citrate (Viagra) showed comparable results, according to VIVUS, Inc., maker of TA-1790.